Perinatal Provider Toolkit

Pregnant mother with child touching belly


The Perinatal Provider Toolkit is a centralized online reference to help health care providers quickly access reputable resource information on perinatal substance use for patient treatment and education. The toolkit is for any member of the healthcare team serving pregnant and postpartum women with substance use disorders (SUD) such as:

  • Physicians, physician assistants, nurse practitioners, and nurses in obstetrics/gynecology, family medicine, pediatrics, and psychiatry; and midwives
  • Social workers and case managers
  • Behavioral health and substance use treatment and recovery services
  • Early childhood and home visiting programs

Fact Sheets, infographics, and websites for pregnant and postpartum women, women trying to become pregnant, and the general public that address the impact of substances on maternal, fetal, and infant health. Many resources highlight information that women should share with their providers about substance use, and where they can obtain additional treatment and support. Resources vary in use of language and format for persons with differing literacy skills. Some resources are available in both English and Spanish.

Patient Education

Resources are drawn from reputable sources including the American College of Obstetrics and Gynecology (ACOG); American Academy of Pediatrics (AAP); American Society of Addiction Medicine (ASAM); Centers for Disease Control and Prevention (CDC); March of Dimes; National Institutes of Health; National Institute on Drug Abuse (NIDA); Organization of Teratology Information Specialists; Providers Clinical Support System (PCSS; American Academy of Addiction Psychiatry); and the Substance Abuse & Mental Health Administration (SAMHSA).

Perinatal Provider Toolkit image


Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.